	Clinical Trial Protocol for LPS-Boost: Intensified [(177)Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease. J Nucl Med Iravani A, Gulati R, Miyaoka R, Reiger AC, Chen DL, Kumar M, Erickson M, Nega K, Meyer C, Lira S, Seo Y, Flavell RR, Pritchard CC, Haffner MC, Nadal Rios R, Sunkara R, Khan HM, Yezefski T, Raychaudhuri R, Hsieh AC, Grivas P, Cheng HH, Yu EY, Schweizer MT, Nelson PS, Czernin J, Hope TA, Calais J. PMID: 42595485 [PubMed - as supplied by publisher]
	Solitary fibrous tumour mimicking a urethral caruncle: a diagnostic pitfall. BMJ Case Rep Ono Y, Miyazawa Y, Arai S, Sekine Y, Sugita K. PMID: 42595384 [PubMed - indexed for MEDLINE]
	ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: from molecular mechanisms to clinical targeting. Crit Rev Oncol Hematol Wang Q, Wang J, Zhao Y, Yan J, Zhang Y, Liu Z, Zhao Z, Yu H. PMID: 42595197 [PubMed - as supplied by publisher]
	Real-World Perioperative and Early Oncological Outcomes of Robot-Assisted Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Single-Institution Series of 100 Consecutive Patients. Asian J Endosc Surg Yajima S, Okumura G, Gozu S, Kataoka M, Nakanishi Y, Masuda H. PMID: 42594915 [PubMed - indexed for MEDLINE]
	Treatment and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer by Race, Initial Diagnosis, and Family History: Results From the TRUMPET Registry. Clin Genitourin Cancer Karsh L, Hwang C, Symanowski J, Shevrin D, Elsouda D, Russell D, Spalding J, Kral P, El-Chaar N, Shore N. PMID: 42594809 [PubMed - as supplied by publisher]
	PCaSFUA-Net: Spatial frequency collaboration and uncertainty-aware fusion for multimodal prostate cancer segmentation. Comput Med Imaging Graph Li C, Huang M, Li Y, Li Y, Zhang Y, Long H, Wang T, Bai Z. PMID: 42594737 [PubMed - as supplied by publisher]
	Raising Suspicion Rather than Making a Definitive Diagnosis of Rare Renal Tumor Subtypes. Radiographics Jinzaki M, Nicola R. PMID: 42594024 [PubMed - in process]
	Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial. JAMA Ellis RJ, Pugh SL, Yu JB, Feng FY, Konski AA, Grubb RL 3rd, Wallace RE, Gladstone DJ, Ménard C, Miccio JA, Frazier AJ, Pennington JD, Michalski JM, Spratt DE, Martinez A, Morgan SC, Mihai A, Solanki AA, Amjad A, Straza MW, Delouya G, Schroeder TM, Marshall DT, Kapadia N, Patel AN, Cescon TP, El-Gayed A, Yoon HA, Paulus R, Sandler HM, NRG-GU005 Collaborative Authors. PMID: 42593775 [PubMed - as supplied by publisher]
	Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center. World J Urol Bertini A, Re C, Salerno L, Musso G, Cei F, Rosiello G, Barretta A, Belladelli F, Piccolo C, Disabato N, Campugiani A, Montesano M, Ficarra G, Tenace N, Colecchia M, Ponzoni M, Cigliola A, Necchi A, Briganti A, Bertini R, Salonia A, Montorsi F, Larcher A, Capitanio U. PMID: 42593572 [PubMed - indexed for MEDLINE]
	Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation. World J Urol Raskin Y, Baekelandt F, Decaestecker K, Seront E, Grisay G, De Sutter T, Bailly M, Noujeim JP, Maes H, De Smedt L, Waltregny D, Brochier W, Roumeguère T, Tombal B. PMID: 42593560 [PubMed - indexed for MEDLINE]
	The molecular underpinnings of the immune landscape in prostate cancer: decoding a "cold" tumor. Front Oncol Li K, Yang W, Huang D. PMID: 42591989 [PubMed]
	Network analysis of core symptom changes in Chinese patients undergoing radical prostatectomy for prostate cancer: a longitudinal study. Front Oncol Huang X, Huang X, Shi Y, Li W, Zheng G. PMID: 42591611 [PubMed]
	Ambient aromatic hydrocarbons and prostate cancer: mechanistic evidence linking benzene and PAH exposure to tumor progression. Front Cell Dev Biol Wu H, Cao H, Ye Z, Li Z, Chang M, Zhang W, Xu T, Wang L, Yang T, Deng X, Hu E, Gao B. PMID: 42591383 [PubMed]
	Dietary spermidine intake is not associated with prostate cancer incidence or prostate cancer-specific mortality: findings from the prostate, lung, colorectal, and ovarian cancer screening trial. Front Nutr Wang G, Lin J, Lin Z, Jian J, Xu J, Xie J, Liu S, Chen Q, Zhong D. PMID: 42591195 [PubMed]
	Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB-amplified renal cell carcinoma: a comprehensive studyÂ of 15 cases. Histopathology Zullow H, Tjota MY, Kwon JW, Antic T. PMID: 42591048 [PubMed - as supplied by publisher]
	Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis. Cancer Martinez C, Chen D, Leong R, Lum N, Xiao K, Almasri L, Kollmannsberger CK, Raman S. PMID: 42590929 [PubMed - indexed for MEDLINE]
	The Diagnostic and Prognostic Value of Immunohistochemical Markers in Bladder Cancer: A Real-World Study of 477 Patients. J Clin Med Tang X, Liu J, Zhao Q, Yang X, Yang Y, Du P. PMID: 42590225 [PubMed]
	The Use of Extracorporeal Organ Support Therapies for Acute Kidney Injury in Cancer Patients. J Clin Med Ati, Forni L, Premu. PMID: 42590126 [PubMed]
	Stem Cell-Delivered Cytosine Deaminase/5-Fluorocytosine and TRAIL Gene Therapy for Castration-Resistant Prostate Cancer: Translational Synthesis and First-in-Human Trial Concept. Int J Mol Sci Kim JH, Song M, Lee K, Lee SH, Song YS. PMID: 42589524 [PubMed - indexed for MEDLINE]
	Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR. Int J Mol Sci Santini N, Procino A, Ljubi, , Ugarkovi, Feliciello I. PMID: 42589489 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180707

Page 1 of 9036



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy